FindTrial
Sign In

TO COMPARE EFFICACY OF DEXMEDETOMIDINE AND NALBUPHINE FOR TREATMENT OF POSTSPINAL SHIVERING

COMPARATIVE STUDY TO EVALUATE THE EFFICACY OF INTRAVENOUS DEXMEDETOMIDINE AND NALBUPHINE FOR TREATMENT OF POST SPNIAL SHIVERING

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/014854
Enrollment
80
Registered
2018-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients posted for elective surgery under spinal anaesthesia who develop post spinal shivering

Interventions

Intervention1: DEXMEDETOMIDINE,: INTRAVENOUS DEXMEDETOMIDINE GIVEN DOSE 0.5micro gm /kg OVER 2 MIN Control Intervention1: NALBUPHINE: INTRAVENOUS NALBUPHINE GIVEN DOSE 0.08 mg/kg OVER 2 MIN

Sponsors

Dr Harpreet kaur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I-II Patients during elective surgeries who develop post spinal shivering

Exclusion criteria

Exclusion criteria: 1.Patientâ??s refusal for surgery under spinal anaesthesia 2.Any Contraindication to regional anaesthesia 3.Known hypersensitivity to dexmedetomidine or nalbuphine 4.ASA grade III and IV 5.Shivering due to allergic reaction to blood / blood products and other drugs administered during surgery. 6.Pregnancy

Design outcomes

Secondary

MeasureTime frame
Haemodynamic parameters, Adverse EffectsTimepoint: every 5 mins for 30 mins and every 15 mins upto 120 mins after spinal—

Primary

MeasureTime frame
Response time, success rate, Recurrence of shivering after successTimepoint: every 5 mins for 30 mins and every 15 mins upto 120 mins after spinal—

Countries

India

Contacts

Public ContactDr Sarvjeet Kaur

GGS medical college and hospital

drsarvjeetk@gmail.com9915680508

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026